Be one of the first and get the chance to win an exclusive price...!
For meeting slot reservations with Federico Pollano - Managing Director
of Richter-Helm BioTec and Dr. Kai Pohlmeyer - Head of Business
Development at Richter-Helm please contact: Britta Soltau -b.soltau@richter-helm-biotec.eu
Richter-Helm offers: Biopharmaceutical Development and Manufacturing of
• recombinant proteins
• plasmid DNA
• vaccines
Manufacturing Capabilities
• from strain development to API production
• from lab scale to 1500 L large scale manufacturing
Partnering and Licensing
• full development up to finished product
• global in- and out-licensing of biopharmaceutical projects
AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC
AMRI, a global contract services organization, announced today that it has entered into a preferred provider agreement with BioPontis Alliance LLC. The agreement is aimed at supporting BioPontis’ mission to bridge the gap between early-stage research and technologies being discovered and developed in academia and other research entities. AMRI will provide its services in small molecule discovery, development, and manufacturing in BioPontis’ drug discovery research programs. The agreement also supports the need for proof-of-concept data that is required in the current pharmaceutical company licensing environment. The goal of BioPontis Alliance is to identify promising early stage product opportunities and utilize a preferred network of CROs and leading research companies to apply appropriate expertise to develop these opportunities enough to attract pharmaceutical company licensing partners. More info >>
10-12 April 2012, Gaylord National Hotel and Convention Center, Washington, US
The 12th annual World Vaccine Congress Washington brings new scientific and business critical debate, discussion and solutions from the true global pioneers shaping vaccine R&D. More info >>
